E-LIB Suche - Ergebnisse für: Vania Hungria

1

COVID-19 in multiple myeloma patients: frequencies and risk..:

Garnica, Marcia ; Crusoe, Edvan De Queiroz ; Ribeiro, Glaciano...
Hematology, Transfusion and Cell Therapy. 46 (2024) 2 - p. 153-160 , 2024

Link: https://doi.org/10.1016/..

2

HSCT FOR MONOCLONAL GAMMOPATHIES: MULTIPLE MYELOMA AND AMYL..:

Maiolino, Angelo ; Hallack Neto, Abrahao Elias ; Crusoe, Edvan...
JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 4 (2023) 1 - p. 179 , 2023

Link: https://doi.org/10.46765..

3

S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING TH..:

Dimopoulos, Meletios A. ; Hungria, Vania ; Radinoff, Atanas...
HemaSphere. 7 (2023) S3 - p. e072005a , 2023

Link: https://doi.org/10.1097/..

4

P-052 LINKER-MM3, a phase 3, open-label, randomized study o..:

Weisel, Katja ; Hungria, Vania ; Quach, Hang...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S63-S64 , 2023

Link: https://doi.org/10.1016/..

5

MM-510 Patient-Reported Outcomes in Patients With Relapsed ..:

Hungria, Vania ; Weisel, Katja ; Currie, Brooke...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S505 , 2023

Link: https://doi.org/10.1016/..

6

POSTER: MM-510 Patient-Reported Outcomes in Patients With R..:

Hungria, Vania ; Weisel, Katja ; Currie, Brooke...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S224 , 2023

Link: https://doi.org/10.1016/..

7

P954: MULTIPLE MYELOMA IN LATIN AMERICA CANCER REGISTRY: TH..:

Hungria, Vania ; Gaiolla, Rafael ; Galvez, Kenny...
HemaSphere. 7 (2023) S3 - p. e6700375 , 2023

Link: https://doi.org/10.1097/..

8

PB2133: TRIAL IN PROGRESS: LINKER-MM3, A PHASE 3, OPEN-LABE..:

Weisel, Katja ; Hungria, Vania ; Quach, Hang...
HemaSphere. 7 (2023) S3 - p. e465366a , 2023

Link: https://doi.org/10.1097/..

9

CAR-T cell therapy for multiple myeloma: a practical toolki..:

Hungria, Vania ; Piérola, Ana Alfonso ; Filho, Jayr Schmidt...
Hematology, Transfusion and Cell Therapy. 45 (2023) 2 - p. 266-274 , 2023

Link: https://doi.org/10.1016/..

10

P-252 Impact of belantamab mafodotin vs pomalidomide/low-do..:

Dimopoulos, Meletios ; Weisel, Katja ; Hungria, Vania...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S174-S175 , 2023

Link: https://doi.org/10.1016/..

11

P-140 Multiple myeloma in Latin America cancer registry: th..:

Hungria, Vania ; Gaiolla, Rafael ; Galvez, Kenny...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S112-S113 , 2023

Link: https://doi.org/10.1016/..

12

P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/R..:

Hungria, Vania ; Weisel, Katja ; Currie, Brooke...
HemaSphere. 7 (2023) S3 - p. e35249ae , 2023

Link: https://doi.org/10.1097/..

13

P-130: Brazilian ineligible multiple myeloma patients: real..:

Crusoe, Edvan ; Ribeiro, Glaciano ; Zanella, Karla...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S106-S107 , 2022

Link: https://doi.org/10.1016/..

14

P-260: Daratumumab (DARA) plus bortezomib and dexamethasone..:

Mateos, María-Victoria ; Richardson, Paul ; Weisel, Katja...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S179-S180 , 2022

Link: https://doi.org/10.1016/..

15

Health‐related quality of life in patients with light chain..:

Sanchorawala, Vaishali ; Palladini, Giovanni ; Minnema, Monique C....
American Journal of Hematology. 97 (2022) 6 - p. 719-730 , 2022

Link: https://doi.org/10.1002/..